Bioventus (BVS) Gross Profit Growth (1y) (2021 - 2026)
Bioventus (BVS) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 8.95% |
| 10 | Bioventus | 969.51 Mn | 940.05 Mn | 105.67 Mn | 3.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 3.50% |
| Mar 28, 2026 | 9.29% |
| Dec 31, 2025 | 5.97% |
| Sep 27, 2025 | 0.72% |
| Jun 28, 2025 | -1.49% |
| Mar 29, 2025 | -6.02% |
| Dec 31, 2024 | 18.95% |
| Sep 28, 2024 | 18.64% |
| Jun 29, 2024 | 16.29% |
| Mar 30, 2024 | 19.56% |
| Dec 31, 2023 | 16.33% |
| Sep 30, 2023 | -6.73% |
| Jul 1, 2023 | -7.79% |
| Apr 1, 2023 | -2.36% |
| Dec 31, 2022 | -15.47% |
| Oct 1, 2022 | 6.91% |
| Jul 2, 2022 | 26.65% |
| Apr 2, 2022 | 27.11% |
| Dec 31, 2021 | 19.46% |
| Oct 2, 2021 | 26.58% |